The National Institutes of Health stressed Tuesday that its upcoming initiative to fast-track mRNA cancer vaccines should be interpreted with extreme caution, noting that the eradication of tumors is not a guarantee of immortality.
The National Institutes of Health stressed Tuesday that its upcoming initiative to fast-track mRNA cancer vaccines should be interpreted with extreme caution, noting that the eradication of tumors is currently only associated with continued breathing.
The program, set to launch in December on a timeline mirroring the rapid Covid-19 rollout, has prompted immediate pushback from cautious epidemiologists. A peer-reviewed paper published this week warned that while early trials show a strong correlation between the vaccines and living to see retirement, further observation is necessary to rule out confounding variables such as diet, exercise, or spontaneous cellular luck.
While trial participants experienced a sudden cessation of dying, we must remember that survival is a highly subjective metric.
The Food and Drug Administration has similarly urged the public not to rush to conclusions about the treatment. Regulators point out that the mechanism relies on immune system stimulation, which researchers warn has not yet been definitively proven to cause the long-term health it appears to trigger in a statistically significant manner.
The agency issued a supplementary bulletin reminding citizens that even if the experimental shots prove to be a complete success, dying of natural causes remains a highly prevalent, irreversible endpoint requiring continuous longitudinal observation.